How should nausea be assessed in patients receiving chemotherapy?
- 1 June 1991
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 18 (2) , 85-93
- https://doi.org/10.1016/0305-7372(91)90008-n
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Assessment of nauseaEuropean Journal of Clinical Pharmacology, 1990
- Double-Blind Randomized Cross-Over Trial of Dexamethasone and Prochlorperazine as Anti-Emetics for Cancer ChemotherapyOncology, 1989
- Prevalence, predictors, and course of anticipatory nausea in women receiving adjuvant chemotherapy for breast cancerCancer, 1988
- Antiemetic efficacy of high-dose dexamethasone: Randomized, double-blind, crossover study with a combination of dexamethasone, metoclopramide and diphenhydramineBritish Journal of Cancer, 1988
- Review: The Management of Nausea and Vomiting in Clinical OncologyThe Lancet Healthy Longevity, 1987
- Nabilone: an alternative antiemetic for cancer chemotherapy.Archives of Disease in Childhood, 1986
- Antiemetic efficacy of high-dose corticosteroids and droperidol in cisplatin-induced emesis: A controlled trial with droperidol and metoclopramideGynecologic Oncology, 1984
- A randomized trial of metoclopramide and a combination of dexamethasone and lorazepam for prevention of chemotherapy-induced vomiting.Journal of Clinical Oncology, 1984
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Dose: A critical factor in cancer chemotherapyThe American Journal of Medicine, 1980